An official website of the United States government
Home
Name
Dalotuzumab
Alternate Names
MK-0646
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Humanized monoclonal antibody
NSC Number
None
Primary Site
Colorectal
NSCLC
pancreas
Histology
None
Remarks
As of November 2015, this drug is still in clinical trials and has not yet received FDA approval. Code in Other Treatment and assign code 2 until final approval received.
Coding
This drug should be coded
